Key result
Prior polyvascular disease in three arterial beds is linked to ~31% higher in-hospital ischemic risk.
Why the study?
PAD or CVD is associated with higher likelihood of significant CAD, but the prevalence and impact of pre-existent polyvascular disease in non-ST-segment elevation ACS needed assessment.
Does prior polyvascular disease increase the risk of in-hospital adverse events in patients presenting with non-ST-segment elevation acute coronary syndrome?
Cohort (n=95,749)
Yes
Does prior polyvascular disease increase the risk of in-hospital adverse events in patients presenting with non-ST-segment elevation acute coronary syndrome?
In patients with non-ST-segment elevation acute coronary syndrome, the presence of prior polyvascular disease is associated with a stepwise increase in the risk of in-hospital ischemic events and mortality.
Answers are grounded in this paper and cite their sources.
Polyvascular disease flags higher-risk NSTE-ACS patients; leaves open whether intensified therapy improves outcomes.
AIMS: The presence of peripheral arterial disease (PAD) or cerebrovascular disease (CVD) is associated with higher likelihood of significant coronary artery disease (CAD). We sought to assess the prevalence of PAD, CVD, prior CAD, or pre-existent disease in multiple arterial territories ('polyvascular' disease) in patients presenting with non-ST-segment elevation acute coronary syndrome and its impact on adverse events. METHODS AND RESULTS: Data from 95 749 patients enrolled from February 2003 to September 2006 at 484 sites in the CRUSADE registry were analysed. Patients were categorized as having prior 0, 1, 2, or 3 affected arterial beds. The rates of in-hospital mortality, myocardial infarction, stroke, and congestive heart failure were analysed, as were the rates of non-bypass surgery-related red blood cell transfusion and major bleeding. On presentation, 11,345 (11.9%) patients had established PAD, 9973 (10.4%) had documented CVD, and 41,404 (43.2%) had prior CAD. In this cohort, 0, 1, 2, and 3 arterial bed disease before presentation was present in 46 814 (48.9%, 95% CI 48.6-49.2%), 36 704 (38.3%, 95% CI 37.8-39.0%), 10 675 (11.2%, 95% CI 10.9-11.9%), and 1556 (1.6%, 95% CI 1.5-1.8%) patients, respectively. The rates of ischaemic events increased with the number of affected vascular beds. The adjusted odds ratio for the composite of in-hospital ischaemic events for pre-existent disease in 1, 2, or 3 arterial beds (compared with 0 arterial bed involvement) increased from 1.07 to 1.26 to 1.31 (P < 0.001). Similarly, the adjusted odds ratio for transfusion increased with greater disease burden from 1.11 to 1.28 to 1.30 (P < 0.001), although the adjusted rates of protocol-defined non-bypass surgery-related major bleeding did not. CONCLUSION: Prior polyvascular disease increases the risk of in-hospital adverse events, including mortality. Identification of these patients in clinical trial and real world populations may provide an opportunity to reduce their excess risk with intensive secondary prevention efforts.
No takes yet. Share an insight, caveat, or question.
Bhatt et al. (2009) conducted a cohort in Non-ST-segment elevation acute coronary syndrome (n=95,749). Prior polyvascular disease (1, 2, or 3 affected arterial beds) vs. 0 affected arterial beds was evaluated on Composite of in-hospital ischaemic events (OR 1.31, p=<0.001). Prior polyvascular disease in 1, 2, or 3 arterial beds increased the risk of in-hospital ischaemic events compared with 0 arterial beds.
Synapse has enriched 10 related papers. Consider them for comparative context: